A decision has been made to make -interferon free of charge to certain MS patients in New Zealand

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.248, 2000-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The limit set for fully subsidising interferon- for MS in New Zealand has been reached

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 307, 2001-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Lamivudine [`Zeffix'; Glaxo Wellcome] has been launched in a new indication in New Zealand

Inpharma, Vol. 1, Iss. 1259, 2000-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Reclassification of orlistat [Xenical; Roche] as a pharmacist-only medicine has been recommended in New Zealand (NZ)

Inpharma, Vol. 1, Iss. 1474, 2005-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

A 23% market share of new prescriptions for hepatitis C in the US has been captured by Roche's antiviral agent PEG-interferon (IFN)- -2a

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 402, 2003-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Interferon- -1b reimbursable for MS patients in Canada

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 247, 2000-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite